BRTX
Price
$1.55
Change
+$0.10 (+6.90%)
Updated
Dec 20, 04:59 PM (EDT)
67 days until earnings call
MPSYF
Price
$73.27
Change
+$1.51 (+2.10%)
Updated
Jul 9 closing price
Ad is loading...

BRTX vs MPSYF

Header iconBRTX vs MPSYF Comparison
Open Charts BRTX vs MPSYFBanner chart's image
BioRestorative Therapies
Price$1.55
Change+$0.10 (+6.90%)
Volume$862
CapitalizationN/A
MorphoSys AG
Price$73.27
Change+$1.51 (+2.10%)
Volume$3.5K
CapitalizationN/A
BRTX vs MPSYF Comparison Chart
Loading...
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRTX vs. MPSYF commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRTX is a Hold and MPSYF is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (BRTX: $1.55 vs. MPSYF: $73.27)
Brand notoriety: BRTX and MPSYF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRTX: 26% vs. MPSYF: 100%
Market capitalization -- BRTX: $10.73M vs. MPSYF: $2.76B
BRTX [@Biotechnology] is valued at $10.73M. MPSYF’s [@Biotechnology] market capitalization is $2.76B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRTX’s FA Score shows that 1 FA rating(s) are green whileMPSYF’s FA Score has 1 green FA rating(s).

  • BRTX’s FA Score: 1 green, 4 red.
  • MPSYF’s FA Score: 1 green, 4 red.
According to our system of comparison, MPSYF is a better buy in the long-term than BRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRTX’s TA Score shows that 6 TA indicator(s) are bullish.

  • BRTX’s TA Score: 6 bullish, 2 bearish.

Price Growth

BRTX (@Biotechnology) experienced а +6.90% price change this week, while MPSYF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

BRTX is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MPSYF($2.76B) has a higher market cap than BRTX($10.7M). MPSYF YTD gains are higher at: 78.707 vs. BRTX (-10.914).
BRTXMPSYFBRTX / MPSYF
Capitalization10.7M2.76B0%
EBITDA-11.9MN/A-
Gain YTD-10.91478.707-14%
P/E RatioN/AN/A-
Revenue377KN/A-
Total Cash13.1MN/A-
Total Debt42.4KN/A-
FUNDAMENTALS RATINGS
BRTX vs MPSYF: Fundamental Ratings
BRTX
MPSYF
OUTLOOK RATING
1..100
250
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
6342
P/E GROWTH RATING
1..100
10018
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BRTX's Valuation (28) in the null industry is somewhat better than the same rating for MPSYF (89). This means that BRTX’s stock grew somewhat faster than MPSYF’s over the last 12 months.

BRTX's Profit vs Risk Rating (100) in the null industry is in the same range as MPSYF (100). This means that BRTX’s stock grew similarly to MPSYF’s over the last 12 months.

BRTX's SMR Rating (98) in the null industry is in the same range as MPSYF (98). This means that BRTX’s stock grew similarly to MPSYF’s over the last 12 months.

MPSYF's Price Growth Rating (42) in the null industry is in the same range as BRTX (63). This means that MPSYF’s stock grew similarly to BRTX’s over the last 12 months.

MPSYF's P/E Growth Rating (18) in the null industry is significantly better than the same rating for BRTX (100). This means that MPSYF’s stock grew significantly faster than BRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BRTXMPSYF
RSI
ODDS (%)
Bullish Trend 2 days ago
65%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
27%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
27%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME29.820.82
+2.83%
GameStop Corp
AAPL254.494.70
+1.88%
Apple
SPY591.157.02
+1.20%
SPDR® S&P 500® ETF Trust
BTC.X97755.930000264.976560
+0.27%
Bitcoin cryptocurrency
TSLA421.06-15.11
-3.46%
Tesla

BRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRTX has been loosely correlated with TCRT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BRTX jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRTX
1D Price
Change %
BRTX100%
+6.90%
TCRT - BRTX
33%
Loosely correlated
+0.45%
ETNB - BRTX
32%
Poorly correlated
+12.80%
CERO - BRTX
29%
Poorly correlated
+5.19%
GRCE - BRTX
28%
Poorly correlated
-5.67%
CYYNF - BRTX
26%
Poorly correlated
N/A
More

MPSYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MPSYF has been loosely correlated with HOFBF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MPSYF jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MPSYF
1D Price
Change %
MPSYF100%
N/A
HOFBF - MPSYF
42%
Loosely correlated
N/A
FDMT - MPSYF
42%
Loosely correlated
+9.26%
QRON - MPSYF
35%
Loosely correlated
N/A
ARWR - MPSYF
31%
Poorly correlated
-0.18%
BRTX - MPSYF
22%
Poorly correlated
+6.90%
More